There are many companies that promise AI for drug discovery such as ChatGPT from OpenAI, Anthropic’s AI suite and Perplexity and there are more companies coming up too.
One specific company that is unusual is that it seems to be promising much more deeper understanding of the drug discovery pathways then the others. It can search based upon questions that are more biological, but also has multiple agents that would go and look into specific areas that would be critical for the drug discovery process. For example, they have a clinical study design agent that offers clinical study design for early protocol planning. It might be worth understanding where is the training data coming from?
Such multiple AI agents have great potential to catalyze drug discovery since they take the routine out of the scientific process and let you focus on the creative aspect.
Check them out here: https://www.cheiron.bio/
